{"independent continuant": ["continuant"], "realizable entity": ["specifically dependent continuant"], "specifically dependent continuant": ["continuant"], "role": ["realizable entity"], "generically dependent continuant": ["continuant"], "material entity": ["independent continuant"], "process profile": ["process"], "molecular entity": ["material entity", "chemical entity"], "chemical entity": ["material entity"], "secondary identifier": ["information content entity"], "australian new zealand clinical trials registry identifier": ["clinical trial registry identifier"], "australian new zealand clinical trials registry": ["primary registry"], "peruvian clinical trial registry identifier": ["clinical trial registry identifier"], "masking design": ["study design"], "non - random allocation": ["allocation"], "study summary result": ["report"], "secondary outcome measure information": ["outcome specification"], "iranian registry of clinical trials": ["primary registry"], "other outcome measure information": ["outcome specification"], "indian clinical trials registry": ["primary registry"], "the netherlands national trial register": ["primary registry"], "iranian registry of clinical trials identifier": ["clinical trial registry identifier"], "german clinical trials register identifier": ["clinical trial registry identifier"], "cuban public registry of clinical trials": ["primary registry"], "clinical trial outcome measurement": ["assay"], "pan african clinical trial registry": ["primary registry"], "the netherlands national trial register identifier": ["clinical trial registry identifier"], "japic clinical trials registry": ["primary registry"], "pan african clinical trial registry identifier": ["clinical trial registry identifier"], "chinese clinical trail registry identifier": ["clinical trial registry identifier"], "lebanese clinical trials registry": ["primary registry"], "german clinical trials register": ["primary registry"], "jmacct clinical trials registry": ["primary registry"], "number of participants": ["data item"], "brazilian clinical trial registry identifier": ["clinical trial registry identifier"], "clinical trial phase 2 / 3": ["clinical trial phase"], "study result": ["data item"], "healthy volunteer criterion": ["inclusion criterion"], "primary outcome measure information": ["outcome specification"], "eu clinical trials register": ["primary registry"], "umin clinical trials registry": ["primary registry"], "outcome measure result": ["report"], "korean clinical trials registry": ["primary registry"], "phase not applicable": ["clinical trial phase"], "retrospective study design": ["study design"], "international standard randomised controlled trial register identifier": ["clinical trial registry identifier"], "clinical trial phase 1 / 2": ["clinical trial phase"], "prospective study design": ["study design"], "thai clinical trials registry identifier": ["clinical trial registry identifier"], "chinese clinical trial registry": ["primary registry"], "thai clinical trials registry": ["primary registry"], "outcome specification": ["directive information entity"], "indian clinical trial registry identifier": ["clinical trial registry identifier"], "brazilian clinical trials registry": ["primary registry"], "cuban public registry of clinical trials identifier": ["clinical trial registry identifier"], "lebanese clinical trials registry identifier": ["clinical trial registry identifier"], "primary registry": ["clinicaltrial .gov registry"], "peruvian clinical trial registry": ["primary registry"], "sri lanka clinical trials registry": ["primary registry"], "clinicaltrial .gov registry": ["clinical trials registry organization"], "clinical trials registry organization": ["registry"], "double blinded design": ["masking design"], "single blinded design": ["masking design"], "open blinded design": ["masking design"], "sequential design": ["intervention design"], "single arm design": ["intervention design"], "clinical trial primary purpose specification": ["objective specification"], "clinical trial phase": ["process quality"], "clinical trial early phase 1": ["clinical trial phase"], "clinical trial phase 1": ["clinical trial phase"], "clinical trial phase 2": ["clinical trial phase"], "clinical trial phase 3": ["clinical trial phase"], "clinical trial phase 4": ["clinical trial phase"], "early phase 1 clinical trial": ["clinical trial"], "usa national clinical trial identifier": ["clinical trial registry identifier"], "clinical trial primary completion date": ["study completion date"], "clinical trial study completion date": ["study completion date"], "title of clinical trial": ["textual entity"], "lay title of clinical trial": ["title of clinical trial"], "official title of clinical trial": ["title of clinical trial"], "clinical trial": ["interventional study"], "drug product": ["material entity"], "epidemiological study": ["human subject study"], "medical device": ["material entity"], "feasibility study": ["human subject study"], "registry": ["organization"], "objective specification": ["directive information entity"], "action specification": ["directive information entity"], "data item": ["information content entity"], "information content entity": ["generically dependent continuant"], "directive information entity": ["information content entity"], "curation status specification": ["data about an ontology part"], "report": ["document"], "data about an ontology part": ["data item"], "plan specification": ["directive information entity"], "textual entity": ["information content entity"], "document": ["information content entity"], "postal address": ["textual entity"], "centrally registered identifier": ["information content entity"], "contact affiliation": ["textual entity"], "clinical trial final report": ["report"], "patient registry study": ["observational study"], "device feasibility study": ["feasibility study"], "study type": ["planned process"], "random allocation": ["allocation"], "study primary purpose": ["plan specification"], "gene therapy": ["medical intervention"], "health services research": ["study primary purpose"], "surgical procedure": ["medical procedure"], "phase i trial": ["clinical trial"], "phase ii trial": ["clinical trial"], "phase iii trial": ["clinical trial"], "phase iv trial": ["clinical trial"], "phase i / ii trial": ["clinical trial"], "phase ii / iii trial": ["clinical trial"], "basic research": ["study primary purpose"], "observational study": ["human subject study"], "condition or disease under study": ["medical condition"], "personal attribute": ["information content entity"], "age": ["personal attribute"], "clinical study protocol": ["study protocol"], "diagnosis study": ["study primary purpose"], "treatment study": ["study primary purpose"], "prevention study": ["study primary purpose"], "planned subject number": ["data item"], "allocation": ["intervention design"], "contact information": ["textual entity"], "clinical study sponsor": ["sponsor"], "study protocol": ["protocol"], "blinded clinical study": ["interventional study"], "screening study": ["study primary purpose"], "supportive care study": ["study primary purpose"], "factorial study": ["interventional study"], "test facility country": ["contact information"], "test facility name": ["contact information"], "study condition": ["condition"], "interventional study": ["human subject study"], "clinical trial registry identifier": ["centrally registered identifier"], "expanded access study": ["human subject study"], "intervention type": ["planned process"], "primary outcome measure": ["data item"], "secondary outcome measure": ["data item"], "adverse event": ["pathological bodily process"], "medical intervention": ["planned process"], "drug administration": ["medical intervention"], "therapeutic intervention": ["medical intervention"], "medical procedure": ["medical intervention"], "planned process": ["process"], "investigation": ["planned process"], "assay": ["planned process"], "responsible party role": ["investigation agent role"], "intervention design": ["study design"], "investigation agent role": ["role"], "sponsor role": ["responsible party role"], "organization": ["material entity"], "protocol": ["plan specification"], "informed consent process": ["planned process"], "device": ["material entity"], "country name": ["textual entity"], "selection criterion": ["directive information entity"], "selection": ["planned process"], "value specification": ["information content entity"], "age group inclusion criterion": ["inclusion criterion"], "minimum age value specification": ["value specification"], "maximum age value specification": ["value specification"], "sex inclusion criterion": ["inclusion criterion"], "case - control study design": ["study design"], "observation design": ["study design"], "study design": ["plan specification"], "repeated measure design": ["intervention design"], "cross over design": ["repeated measure design"], "n - to - 1 design": ["cross over design"], "parallel group design": ["study design"], "factorial design": ["study design"], "eligibility criterion": ["selection criterion"], "inclusion criterion": ["eligibility criterion"], "exclusion criterion": ["eligibility criterion"], "human subject enrollment": ["selection"], "clinical finding": ["data item"], "clinical history": ["data item"], "preclinical finding": ["data item"], "diagnosis": ["data item"], "longitudinal study design": ["study design"], "cohort study design": ["longitudinal study design"], "role in human social processes": ["role"], "legal person role": ["role in human social processes"], "telephone number": ["contact person information"], "contact name": ["contact information"], "medical condition": ["realizable entity"], "clinical investigator": ["investigator"], "clinical trial start date": ["study start date"], "combinational intervention": ["medical intervention"], "behavioral intervention": ["medical intervention"], "facility contact": ["contact person"], "investigator role": ["investigation agent role"], "contact person role": ["role"], "central contact person of study": ["contact person"], "contact person information": ["information content entity"], "primary sponsor role": ["sponsor role"], "secondary sponsor role": ["sponsor role"], "principal investigator role": ["investigator role"], "sponsor investigator role": ["investigator role"], "investigation collaborator role": ["investigation agent role"], "human subject study": ["investigation"], "biological sex": ["organismal quality"], "female": ["phenotypic sex"], "male": ["phenotypic sex"], "phenotypic sex": ["biological sex"], "organismal quality": ["physical object quality"], "condition": ["information content entity"], "vaccination": ["medical intervention"], "phase 1 vaccine trial": ["vaccine clinical trial"], "phase 2 vaccine trial": ["vaccine clinical trial"], "phase 3 vaccine trial": ["vaccine clinical trial"], "phase 4 vaccine trial": ["vaccine clinical trial"], "vaccine clinical trial": ["human subject study"]}